InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Hill Christopher Scott, 首席财务官. Director active across 2 companies, notably Core Laboratories N V. In total, 6 filings have been published. History available since 31 December 2021. The latest transaction was disclosed on 31 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hill Christopher Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
32,152 股@ US$16.0338.8% 占其流量Common StockSEC:0001193125-26-002252:0
14,719 股@ US$17.3135.3% 占其流量Common StockSEC:0000950170-25-001317:0
14,195 股@ US$17.6632.7% 占其流量Common StockSEC:0000950170-24-002890:0
13,870 股@ US$17.6632.0% 占其流量Common StockSEC:0000950170-24-001237:0
12,470 股@ US$20.2739.4% 占其流量Common SharesSEC:0001209191-23-001028:0
9,259 股@ US$22.3143.5% 占其流量Common SharesSEC:0001209191-22-001068:0
6 条申报中的 6 条
About Hill Christopher Scott
Hill Christopher Scott is Chief Financial Officer. He has 6 filings in total, and the sampled recent filings cover the period from 2022-01-04 to 2026-01-05. The buy and sell volumes shown for these recent filings are 0 and 0, and the most frequent transaction nature is tax withholding. The recent filings concern Core Laboratories Inc. /DE/ and Core Laboratories N V, with individual amounts of EUR 438736.4745055537, EUR 244841.5992347989, EUR 237100.4131411687, EUR 226490.2078705204, EUR 221304.6272042352, and EUR 182399.8060277879.
